- Capacity building in vaccinology and vaccine development;
- To prepare students for a career in academia, public health and research and development in public and private vaccine institutes.
- Provide graduates in medicine a Master degree in vaccinology via a tailor made training in immunization, public health and vaccine development. The program is very extensive and complete, covering subjects from epidemiology, health economics, disease burden of vaccine preventable infectious diseases, vaccine development from research to licensure and vaccine policy and funding;
- Collaborative effort between academia and vaccine industry;
- 18-months program, combining theoretical and practical training. The faculty members are worldwide experts from academia, well known international universities, supranational organizations and industry:
- WHO, PATH, EMA, BMGF, GAVI, PEI, IVI, CDC, ECDC, EU Commission, DCVMN, ADITEC, Achille Sclavo Foundation; Sabin Institute, Bio-Manguinhos / Fiocruz, DoH UK and Italy, FAMHP Belgium, Welcome Trust, CHERMID, MRC Gambia, Brighton Collaboration;
- Johns Hopkins Institute, Baltimore, US; Institute Pasteur, Paris, France; Erasmus Medical Center, Rotterdam, Netherlands; Imperial College, London, UK; Karolinska Institute, Stockholm, Sweden; Swiss Tropical Institute, Basel, Switzerland; Carlos Chagas Institute, Rio de Janeiro, Brazil; and other prominent universities and academic institutions from Austria, Belgium, Canada, Germany, Ghana, Greece, Finland, Italy, Mali, Spain, South Africa, UK, US;
- GSK, Novartis, Takeda Vaccines, Sanofi-Pasteur, Pfizer, Roche, GRID Europe & Asia, FIDEC, VisMederi; G-Con, BLF councils, 4Clinics.
Program agenda (11 months):
- Module I: Public Health and Vaccine Development Process;
- Module II: Vaccine Immunology and Preclinical Research;
- Module III: Vaccine Manufacturing and Quality Control Processes;
- Module IV: Infectious Diseases and Vaccine Prevention;
- Module V: Clinical Development Methodology, Biostatistics and Clinical Data management;
- Module VI: Pharmacovigilance;
- Module VII: Epidemiology, Health Systems and Economics;
- Module VIII: Good Clinical Practices, Clinical Quality Assurance and Clinical Trial Operations;
- Module IX: Regulatory Affairs;
- Module X: Policies and Recommendations for Vaccines in the World;
- Extra Curriculum: parallel educational seminars for personal and professional development.
Internship (7 months):
Students will spend:
- 1 month at the University of Siena within its different departments at the university hospital and public health centers;
- 6 months within different departments of the sponsors and collaborative institutions, followed by investigational site training.
- Each student selects a subject for a written thesis;
- The thesis will be submitted to the University of Siena Medical School and evaluated by a panel of experts (written and oral presentation) during the public thesis defense at the end of the 18 months program.
- In order to graduate and receive the official University Master Degree, the students shall pass the following steps:
- First step: students have to pass 10 modules written exams achieving the official minimum grade to proceed to the thesis defense;
- Second step: students have to achieve the minimum thesis grade.
- University degree in Medicine;
- Excellent command of English, written and spoken. The full Master Program is conducted in English;
- Minimum 1-year clinical experience post-graduation.
The technical-Scientific Committee may evaluate for admission applications from candidates with other degrees, provided they have proof of specific activities or degrees in the field of the Master course.
The 5th Edition of the Master Program in Vaccinology will start on June 2017.
The application process is already open, please check the official link:
Candidates must send the official application form to the University of Siena by January 30, 2017.
Assistance or further information to the candidates will be provided by Master Program Coordination. Please send an e-mail to firstname.lastname@example.org by January 10, 2017.